Freedom Caucus Members Roil Colleagues With DC Oversight Proposal

October 4, 2019 by Dan McCue
Freedom Caucus Members Roil Colleagues With DC Oversight Proposal

WASHINGTON – Reps. Paul Gosar, R-Ariz., and Mark Meadows, R-N.C., have stirred up a hornet’s nest of controversy with a proposal that Congress tighten its oversight of the District of Columbia.

H.R. 4445, the District of Columbia Home Rule Improvement Act, would double the congressional review period for legislation passed by the D.C. Council from 30 days to 60 days, expand the expedited parliamentary procedures for disapproving D.C. legislation, and clarify that Congress can disapprove of individual provisions of D.C. legislation. 

On Friday, James McGovern, D-Mass., chairman of the House Rules Committee, one of two committees to which the bill has been referred, condemned the legislation, declaring it both an attack on the District and dead on arrival.

“It is ironic that members of the Freedom Caucus have introduced legislation to give the federal government increased ability to meddle in the local affairs of the D.C. government,” McGovern said. “The federal government has no business overriding the will of local residents. Small government conservatives should be outraged by H.R. 4445, but instead they are leading the charge to try and get it passed.”

The introduction of the legislation comes as the House is preparing to consider H.R. 51, the Washington, D.C. Admission Act — legislation that would admit the State of Washington, D.C. into the Union.

McGovern said Friday the House needs “to pass the Washington, D.C. Admission Act and finally make the District a state – not try to restrict the District from governing itself.”

But a spokesman for Representative Meadows told The Well News Friday afternoon, “Our response is that Article 1, Section 8 of the Constitution gives Congress authority and oversight over the capital — or Washington, D.C.”

Representative Gosar’s office did not respond to a request for comment.

Under the Home Rule Act of 1973, most D.C. legislation takes effect after a 30-day congressional review period, unless during that period a resolution of disapproval is enacted into law. 

District bills affecting certain criminal law titles of the D.C. Code are already subject to a 60-day review period, and during the congressional review period, Members of Congress can use fast-track procedures to bring a disapproval resolution to the floor. 

Representative Eleanor Holmes Norton, D-D.C., scoffed at the bill, saying Congressional Republicans made the review period for D.C. legislation an anachronism a long time ago.

Republicans typically prefer to use the appropriations process to try to meddle in local D.C. affairs and repeal D.C. legislation, she said in a lengthy release put out by her office. 

“Voted into the minority in the House, Gosar and Meadows must have a lot of time on their hands,” Norton said.  “When I was in the minority, though, I consistently got bills passed that helped my constituents, and their constituents expect them to do the same. 

“As the House proceeds with the markup of H.R. 51, these two Members are stuck in the anti-home-rule era, which passed into the night even before passage of H.R. 51.  Members of Congress sponsoring legislation that deprecates American citizens are unworthy of their office. I will stop this latest gratuitous bill in its tracks,” she said.

A+
a-
  • District of Columbia
  • Freedom Caucus
  • James McGovern
  • MarkMeadows
  • Paul Gosar
  • In The News

    Health

    Voting

    In The News

    March 27, 2024
    by TWN Staff
    Rep. Cleaver New Co-Chair of House Renewable Energy and Energy Efficiency Caucus

    WASHINGTON — Rep. Emanuel Cleaver II, D-Mo., is the new Democratic co-chair of the House Renewable Energy and Energy Efficiency... Read More

    WASHINGTON — Rep. Emanuel Cleaver II, D-Mo., is the new Democratic co-chair of the House Renewable Energy and Energy Efficiency Caucus. He was invited to serve as co-chair by Sens. Jack Reed, D-R.I., and Mike Crapo, R-Idaho, the co-chairs of the Senate Renewable Energy and Energy... Read More

    March 27, 2024
    by Dan McCue
    One-Time Treatment Could Revitalize Immune Systems in the Elderly

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

    March 27, 2024
    by Dan McCue
    Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

    March 27, 2024
    by Dan McCue
    New Dem Chair Kuster Announces Retirement Following 2024 Election

    CONCORD, N.H. — Rep. Annie Kuster, D-N.H., who, among other things, is the current chair of the New Democrat Coalition... Read More

    CONCORD, N.H. — Rep. Annie Kuster, D-N.H., who, among other things, is the current chair of the New Democrat Coalition in the House, revealed Wednesday that she will not seek reelection to Congress this year. In a lengthy statement released by her office, Kuster gives no... Read More

    March 26, 2024
    by Tom Ramstack
    Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

    March 26, 2024
    by Dan McCue
    Consumers Warned to Avoid Certain Topical Pain Relief Products 

    WASHINGTON — The Food and Drug Administration warned consumers on Tuesday not to use certain over-the-counter pain relief products marketed... Read More

    WASHINGTON — The Food and Drug Administration warned consumers on Tuesday not to use certain over-the-counter pain relief products marketed for topical use before, during or after certain cosmetic procedures. The warning came after the agency issued warning letters to six companies for marketing these products... Read More

    News From The Well
    scroll top